These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 34551378)
21. Cytogenetic Evolution Associated With Disease Progression in Hematopoietic Neoplasms With t(8;22)(p11;q11)/BCR-FGFR1 Rearrangement. Wang W; Tang G; Kadia T; Lu X; Li Y; Huang L; Montenegro-Garreaud X; Miranda RN; Wang SA J Natl Compr Canc Netw; 2016 Jun; 14(6):708-11. PubMed ID: 27283163 [TBL] [Abstract][Full Text] [Related]
22. Functional characterization of two rare BCR-FGFR1 Barnes EJ; Leonard J; Medeiros BC; Druker BJ; Tognon CE Cold Spring Harb Mol Case Stud; 2020 Apr; 6(2):. PubMed ID: 31980503 [TBL] [Abstract][Full Text] [Related]
23. Molecular and cytogenetic characterization of a novel translocation t(4;22) involving the breakpoint cluster region and platelet-derived growth factor receptor-alpha genes in a patient with atypical chronic myeloid leukemia. Safley AM; Sebastian S; Collins TS; Tirado CA; Stenzel TT; Gong JZ; Goodman BK Genes Chromosomes Cancer; 2004 May; 40(1):44-50. PubMed ID: 15034867 [TBL] [Abstract][Full Text] [Related]
24. Primary cells in BCR/FGFR1-positive 8p11 myeloproliferative syndrome are sensitive to dovitinib, ponatinib, and dasatinib. Landberg N; Dreimane A; Rissler M; Billström R; Ågerstam H Eur J Haematol; 2017 Nov; 99(5):442-448. PubMed ID: 28881484 [TBL] [Abstract][Full Text] [Related]
25. A BCR-JAK2 fusion gene from ins(22;9)(q11;p13p24) in a patient with atypical chronic myeloid leukemia. Xu Y; Yin J; Pan J; Wu C; Wang Q; Yao H; Wu D; Chen S; Sun A Leuk Lymphoma; 2013 Oct; 54(10):2322-4. PubMed ID: 23432689 [No Abstract] [Full Text] [Related]
26. Molecular cytogenetic characterization of Philadelphia-negative rearrangements in chronic myeloid leukemia patients. Bennour A; Bellâaj H; Ben Youssef Y; Elloumi M; Khelif A; Saad A; Sennana H J Cancer Res Clin Oncol; 2011 Sep; 137(9):1329-36. PubMed ID: 21739181 [TBL] [Abstract][Full Text] [Related]
27. ABL gene fuses BCR during t(20;22) results in Philadelphia-negative, but BCR/ABL-positive chronic myeloid leukemia. Ito Y; Shimamoto T; Kuriyama Y; Nakajima A; Sumi M; Watanabe Y; Beppu H; Ohtsubo K; Ohyashiki K Leukemia; 2002 May; 16(5):951-2. PubMed ID: 11986960 [No Abstract] [Full Text] [Related]
28. Proteomic analysis reveals dual requirement for Grb2 and PLCγ1 interactions for BCR-FGFR1-Driven 8p11 cell proliferation. Peiris MN; Meyer AN; Warda D; Campos AR; Donoghue DJ Oncotarget; 2022; 13():659-676. PubMed ID: 35574218 [TBL] [Abstract][Full Text] [Related]
30. A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11) in a patient with acute myeloid leukemia. Cirmena G; Aliano S; Fugazza G; Bruzzone R; Garuti A; Bocciardi R; Bacigalupo A; Ravazzolo R; Ballestrero A; Sessarego M Cancer Genet Cytogenet; 2008 Jun; 183(2):105-8. PubMed ID: 18503828 [TBL] [Abstract][Full Text] [Related]
31. A Ph-negative chronic myeloid leukemia with a complex BCR/ABL rearrangement and a t(6;9)(p21;q34.1). Todorić-Zivanović B; Marisavljević D; Surace C; Cemerikić V; Marković O; Krtolica K; Tatomirović Z; Cikota B; Magić Z; Rocchi M Cancer Genet Cytogenet; 2006 Apr; 166(2):180-5. PubMed ID: 16631477 [TBL] [Abstract][Full Text] [Related]
32. Identification of four new translocations involving FGFR1 in myeloid disorders. Sohal J; Chase A; Mould S; Corcoran M; Oscier D; Iqbal S; Parker S; Welborn J; Harris RI; Martinelli G; Montefusco V; Sinclair P; Wilkins BS; van den Berg H; Vanstraelen D; Goldman JM; Cross NC Genes Chromosomes Cancer; 2001 Oct; 32(2):155-63. PubMed ID: 11550283 [TBL] [Abstract][Full Text] [Related]
33. 8p11 myeloproliferative syndrome preceded by t(8;9)(p11;q33), CEP110/FGFR1 fusion transcript: morphologic, molecular, and cytogenetic characterization of myeloid neoplasms associated with eosinophilia and FGFR1 abnormality. Park TS; Song J; Kim JS; Yang WI; Song S; Kim SJ; Suh B; Choi JR Cancer Genet Cytogenet; 2008 Mar; 181(2):93-9. PubMed ID: 18295660 [TBL] [Abstract][Full Text] [Related]
34. Oncogenic fusion protein BCR-FGFR1 requires the breakpoint cluster region-mediated oligomerization and chaperonin Hsp90 for activation. Peiris MN; Meyer AN; Nelson KN; Bisom-Rapp EW; Donoghue DJ Haematologica; 2020 May; 105(5):1262-1273. PubMed ID: 31439673 [TBL] [Abstract][Full Text] [Related]
35. 8p11 Myeloproliferative syndrome with t(8;22)(p11;q11): A case report. Liu JJ; Meng L Exp Ther Med; 2018 Aug; 16(2):1449-1453. PubMed ID: 30116393 [TBL] [Abstract][Full Text] [Related]
36. Identification of a novel TFG-FGFR1 fusion gene in an acute myeloid leukaemia patient with t(3;8)(q12;p11). Wang T; Wang Z; Zhang L; Wen L; Cai W; Yang X; Pan J; Ruan C; Wu D; Sun A; Chen S Br J Haematol; 2020 Jan; 188(1):177-181. PubMed ID: 31802477 [No Abstract] [Full Text] [Related]
37. A complex chromosome rearrangement forms the BCR-ABL fusion gene in leukemic cells with a normal karyotype. Morris C; Kennedy M; Heisterkamp N; Columbano-Green L; Romeril K; Groffen J; Fitzgerald P Genes Chromosomes Cancer; 1991 Jul; 3(4):263-71. PubMed ID: 1958592 [TBL] [Abstract][Full Text] [Related]
38. [Cytogenetic and molecular studies in patients with chronic myelogenous leukemia without Ph chromosome and with unusual Ph translocation]. Xue YQ Zhonghua Yi Xue Za Zhi; 1993 Apr; 73(4):209-12, 252-3. PubMed ID: 8395313 [TBL] [Abstract][Full Text] [Related]
39. Myeloid/lymphoid neoplasm with eosinophilia and BCR/FGFR1 rearrangement with transformation to cortical T-lymphoblastic lymphoma and erythroid precursors: a case report. Isaza AP; Quintero SC; González LPQ; Córdoba FEA; Olivar AFA; Ocaña JCB J Med Case Rep; 2023 Jan; 17(1):39. PubMed ID: 36698221 [TBL] [Abstract][Full Text] [Related]